首页 | 本学科首页   官方微博 | 高级检索  
     

中国丙型肝炎血清流行病学研究
引用本文:陈园生,李黎,崔富强,邢文革,王璐,贾志远,周脉耕,龚晓红,王富珍,郑徽,罗会明,毕胜利,汪宁,杨维中,梁晓峰. 中国丙型肝炎血清流行病学研究[J]. 中华流行病学杂志, 2011, 32(9): 888-891. DOI: 10.3760/cma.j.issn.0254-6450.2011.09.009
作者姓名:陈园生  李黎  崔富强  邢文革  王璐  贾志远  周脉耕  龚晓红  王富珍  郑徽  罗会明  毕胜利  汪宁  杨维中  梁晓峰
作者单位:中国疾病预防控制中心, 北京,100050
摘    要:目的 了解中国现阶段丙型肝炎病毒(HCV)感染现状。方法利用中国疾病预防控制中心“2006年中国乙型病毒性肝炎血清流行病学调查”保留的血清,以美国Murex 3.0和Ortho 3.0抗-HCV试剂为金标准建立标准血清库,筛选中国抗-HCV检测试剂,并用Chiron HCVRIBA 3.0复核检测结果。结果 中国1~ 59岁人群抗-HCV调整流行率为0.43%(95%CI:0.33%~0.53%),男性和女性抗-HCV流行率分别为0.46%和0.40%,城市和农村人群经调整后均为0.43%。东、中和西部地区人群抗-HCV流行率分别为0.37%(95%CI:0.21%~0.53%)、0.67%(95%CI:0.40%~0.94%)和0.31% (95%CI:0.20% ~ 0.42%),3个地区人群抗-HCV流行率的差异无统计学意义;南方和北方地区人群抗-HCV流行率分别为0.29%(95%CI:0.21%~0.52%)和0.53%(95%CI:0.38% ~ 0.64%)。结论经综合性防治,目前中国属丙型肝炎低流行区。

关 键 词:丙型肝炎  血清流行病学
收稿时间:2011-05-10

A sero-epidemiological study on hepatitis C in China
CHEN Yuan-sheng,LI Li,CUI Fu-qiang,XING Wen-ge,WANG Lu,JIA Zhi-yuan,ZHOU Mai-geng,GONG Xiao-hong,WANG Fu-zhen,ZHENG Hui,LUO Hui-ming,BI Sheng-li,WANG Ning,YANG Wei-zhong and LIANG Xiao-feng. A sero-epidemiological study on hepatitis C in China[J]. Chinese Journal of Epidemiology, 2011, 32(9): 888-891. DOI: 10.3760/cma.j.issn.0254-6450.2011.09.009
Authors:CHEN Yuan-sheng  LI Li  CUI Fu-qiang  XING Wen-ge  WANG Lu  JIA Zhi-yuan  ZHOU Mai-geng  GONG Xiao-hong  WANG Fu-zhen  ZHENG Hui  LUO Hui-ming  BI Sheng-li  WANG Ning  YANG Wei-zhong  LIANG Xiao-feng
Affiliation:Chinese Center for Disease Control and Prevention, Beijing 100050.
Abstract:Objective To better understand and measure the status of hepatitis C virus (HCV) infection, we conducted a sero-epidemiological study using the remaining blood samples and data of the nationwide survey of hepatitis B in Chinese residents which was carried out in 2006.Methods The anti-HCV reagent was screened out from the reagents by the HCV infection blood serum plate with anti-HCV positives or negatives. This plate recognized the Murex 3.0 and Ortho 3.0 reagents as gold standards. Anti-HCV in the blood samples were tested using this reagent and confirmed by Chiron HCV RIBA 3.0 reagents. Results Among the population aged 1 year to 59 year-olds, the overall prevalence rate of anti-HCV was 0.43% (95%CI: 0.33%-0.53% ), with the rates of anti-HCV among males and females as 0.46% and 0.40%, respectively. The prevalence rate of anti-HCV in urban area was 0.43%,and in rural area it was 0.43%. The prevalence rate of anti-HCV in the Eastern, Middle and Western areas were 0.37% (95% CI: 0.21%-0.53% ) , 0.67% (95% CI: 0.40%-0.94% ) and 0.31% (95%CI: 0.20%-0.42% ) respectively. The prevalence rates of anti-HCV for the three areas did not show significant differences, statistically. The prevalence rate of anti-HCV in the South and North areas were 0.29%(95%CI:0.21%-0.52%) and 0.53% (95%CI:0.38%-0.64%)respectively. Conclusion Our data revealed that China was in the low prevalence area for hepatitis C infection and the results also suggested that the comprehensive measures for HCV control and prevention had been successfully achieved in the country.
Keywords:Hepatitis C  Sero-epidemiology
本文献已被 万方数据 PubMed 等数据库收录!
点击此处可从《中华流行病学杂志》浏览原始摘要信息
点击此处可从《中华流行病学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号